Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cordlife Group ( (SG:P8A) ) has provided an announcement.
Cordlife Group Limited is currently facing legal challenges as it received a letter of demand from clients alleging negligence and breach of contract in the storage of cord blood units. The claims, which amount to approximately S$8.7 million, represent less than 10% of the company’s net asset value. While some claims have been resolved or withdrawn, the company is actively engaging with legal advisers to address ongoing issues and is open to negotiations with the claimants.
More about Cordlife Group
Cordlife Group Limited, incorporated in Singapore, operates in the healthcare industry, focusing on the cryopreservation and storage of cord blood units. The company provides services related to the storage of biological materials, primarily targeting clients who wish to preserve cord blood for potential future medical use.
Average Trading Volume: 133,936
Technical Sentiment Signal: Sell
Current Market Cap: S$51.06M
For an in-depth examination of P8A stock, go to TipRanks’ Overview page.